Industry wants FDA to align visible particle classifications and inspections with USP
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsRegulatory NewsJoanne S. EglovitchChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticals